Arctos Medical

Developer of optogenetic therapies for treating retinal degenerative diseases

Biotech & Life Sciences

Sector

Seed

Stage

Biotechnology

Model

01Company Overview

Developer of optogenetic therapies for treating retinal degenerative diseases. The company has designed 'replacement photoreceptors' with an optogene that enable to activate targeted cells.

02Backed By1 investor

+C+ND Capital Fund (f.k.a. NanoDimension)→

03Similar Companies

RV

Is this your company? Claim your profile

Restore Vision

Biotech & Life Sciences

→

BS

Bionic Sight

Biotech & Life Sciences

→

BT

Beacon Therapeutics

Biotech & Life Sciences

→

AT

Atsena Therapeutics

Biotech & Life Sciences

→

P

Pulsesight

Biotech & Life Sciences

→

04Startup DNA

9

signals

Sectors
Business Model
Technology